UPClytics
View all cases

UPC CFI 617/2025

Jul 9, 2025·EP2279254 · NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

Case details
Status
Case Closed
Action
Counterclaim for revocation
Category
Counterclaim for revocation
Parties
Claimants
Representatives
  • Ruben Laddé
Respondents
Representatives
Division
The Hague LD
Technology
  • Chemistry
    Biotechnology · Pharmaceuticals
Language
English
EPO Opposition
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
Patent revokedMedian days to first decision
All UPC37% (34/91)124
The Hague LDLockedLocked
Judge Edger BrinkmanLockedLocked
Judge Margot KokkeLockedLocked
Judge Samuel GranataLockedLocked
Judge Xavier Dorland-GalliotLockedLocked

At the UPC: Moderna Group (20 cases)·Arbutus Biopharma Corporation (12 cases)

This dispute contains 3 other proceedings

UPC APP 18039/2025·UPC APP 25212/2025·UPC APP 27016/2025

1 other defendants litigating the same or a related patent

UPC CFI 191/2025

Start a free trial to see how each one ended.

More cases: The Hague LD·2025

Document titleDatePublic
Case closed2026-08-25Not public
Order2026-08-25Not public
Order2026-08-25Not public
Receipt2026-03-04Not public
Cover sheet2026-03-04Not public
Application document Defendant2026-03-04Not public
Receipt2026-02-25Not public
Cover sheet2026-02-25Not public
Receipt2026-02-25Not public
Cover sheet2026-02-25Not public